A clinical‑stage biotechnology company focused on developing novel therapeutic candidates for serious diseases. The firm operates with limited commercial revenue and relies on capital markets to fund research, making clinical trial results, regulatory milestones, and partnership announcements key dr...
No congressional trades have been disclosed for onspira Therapeutics, Inc. (ONTH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.